Transthyretin Cardiac Amyloidosis Mimicking Immune Checkpoint-Induced Myocarditis in a Patient Treated with Atezolizumab and Bevacizumab for Advanced Hepatocellular Carcinoma: A Case Report

Checkpoint kinase inhibitors are increasingly used in oncology. The combination of atezolizumab and bevacizumab is currently the recommended first-line treatment for advanced hepatocellular carcinoma. Cardiac toxicities of immunotherapies are rare, but can lead to discontinuation of treatment. Trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Bras, Pierrine, Plard, Louise, Le Gouill, Christèle, Piriou, Nicolas, Touchefeu, Yann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830279/
https://www.ncbi.nlm.nih.gov/pubmed/36636682
http://dx.doi.org/10.1159/000526534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830279/
https://www.ncbi.nlm.nih.gov/pubmed/36636682
http://dx.doi.org/10.1159/000526534

Ejemplares similares